Tune in for our session at #EXPERTPE Conference in Leiden on Saturday, Oct 15th, 12 PM CEST with @Erik_Klok_MD moderating the discussion with other international experts around EKOS and its efficacy
Register for the live stream: https://t.co/xSxn1Q7G2r
#VIOCongress2022 is approaching.
Register NOW for our symposium on Thursday 6th October at 5PM CEST to know more about AngioJet and how to better treat Deep Vein Thrombosis (DVT) patients.
#BSCEMEA
1/Today published in @JACCJournals is the 1st global consensus document on IVUS use for lower ext arterial & venous revasc. This document involved >40 international multidisciplinary experts in vascular disease & was led by a 12 person steering committee.
https://t.co/Hzridqneb4
1/Today published in @JACCJournals is the 1st global consensus document on IVUS use for lower ext arterial & venous revasc. This document involved >40 international multidisciplinary experts in vascular disease & was led by a 12 person steering committee.
https://t.co/Hzridqneb4
Don’t miss #LINC2022 live case transmission with Prof Marzia Lugli, to see how Advanced IVUS with OptiCross Catheters brings a new depth of insight and a new level of clarity to your procedures. Add to your calendar now: https://t.co/5LAwnhtpDj #ClinicalEvidence#BSCEMEA#IVUS
EKOS is a safe, repeatable and reliable treatment that dissolves thrombus quickly with low lytic, low blood loss and low trauma – resulting in proven long-term outcomes. #evidencebasedmedicine#whyweEKOS#BSCEMEA https://t.co/OfLNvmjHzz
EKOS is a safe, repeatable and reliable treatment that dissolves thrombus quickly with low lytic, low blood loss and low trauma – resulting in proven long-term outcomes. #evidencebasedmedicine#whyweEKOS#BSCEMEA https://t.co/OfLNvmjHzz
A new standard of care in Superficial Femoral Artery stenting? Hear Prof. Gunnar Tepe (Interventional Radiologist, Germany) discuss the impact of the #EMINENT Randomized Controlled Trial.https://t.co/iAcY9EGGQj
First patient in Europe randomised today in #HIPEITHO outcomes trial of Ekos CDT+anticoag vs anticoag alone @CV_UHB.
Randomisations now ongoing on both sides of the Atlantic. Many thanks to the pts & investigators who help us build the evidence base for new treatment approaches.
Join Prof. O' Sullivan tomorrow sharing tips & tricks to better indenfity VTE events in palliative cancer patients. Don't miss our last symposium at 2.30PM (CET) #CIRSE2021 Click here now: https://t.co/aacE6r7RMv